David Radley

10.0k total citations · 4 hit papers
52 papers, 6.2k citations indexed

About

David Radley is a scholar working on Epidemiology, Microbiology and Surgery. According to data from OpenAlex, David Radley has authored 52 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Epidemiology, 10 papers in Microbiology and 9 papers in Surgery. Recurrent topics in David Radley's work include Cervical Cancer and HPV Research (16 papers), Pneumonia and Respiratory Infections (15 papers) and Hepatitis B Virus Studies (11 papers). David Radley is often cited by papers focused on Cervical Cancer and HPV Research (16 papers), Pneumonia and Respiratory Infections (15 papers) and Hepatitis B Virus Studies (11 papers). David Radley collaborates with scholars based in United States, United Kingdom and Canada. David Radley's co-authors include Eugene Braunwald, Carolyn H. McCabe, Marc Cohen, Peter J. L. M. Bernink, Thomas Horacek, Ramón Corbalán, Elliott M. Antman, Branco Mautner, Richard M. Haupt and Elliott M. Antman and has published in prestigious journals such as New England Journal of Medicine, JAMA and Circulation.

In The Last Decade

David Radley

52 papers receiving 5.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The TIMI Risk Score for Unstable Angina/Non–ST Elevation MI

2000 2.3k citations Marc Cohen, David Radley et al. profile →
Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males

2011 821 citations Anna R. Giuliano, Joel M. Palefsky et al. New England Journal of Medicine profile →
Enoxaparin Prevents Death and Cardiac Ischemic Events in Unstable Angina/Non–Q-Wave Myocardial Infarction

1999 729 citations Elliott M. Antman, Enrique Gurfinkel et al. profile →
HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia

2011 650 citations Joel M. Palefsky, Anna R. Giuliano et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David Radley United States	25	3.1k	2.5k	2.3k	1.3k	801	52	6.2k
Sophia Koo United States	30	520 0.2×	1.4k 0.6×	499 0.2×	74 0.1×	561 0.7×	92	3.6k
Franck Thuny France	46	4.6k 1.5×	6.2k 2.5×	2.9k 1.3×	718 0.5×	159 0.2×	147	10.2k
James P. Steinberg United States	21	694 0.2×	816 0.3×	2.1k 0.9×	110 0.1×	12 0.0×	54	4.1k
José M. Porcel Spain	43	742 0.2×	711 0.3×	1.1k 0.5×	204 0.2×	56 0.1×	237	5.9k
Mary P. Glodé United States	40	1.5k 0.5×	2.1k 0.8×	4.1k 1.8×	121 0.1×	9 0.0×	95	7.4k
Iksung Cho South Korea	32	1.0k 0.3×	1.3k 0.5×	564 0.2×	852 0.6×	6 0.0×	165	3.2k
James G. Donahue United States	35	279 0.1×	2.7k 1.1×	629 0.3×	55 0.0×	34 0.0×	100	5.9k
Catherine Leport France	42	350 0.1×	3.1k 1.2×	680 0.3×	81 0.1×	22 0.0×	121	6.5k
Göran Bratt Sweden	30	393 0.1×	629 0.3×	337 0.1×	40 0.0×	480 0.6×	95	2.9k
George J. Nemo United States	30	205 0.1×	1.9k 0.8×	369 0.2×	85 0.1×	105 0.1×	50	4.7k

Countries citing papers authored by David Radley

Since Specialization

Citations

This map shows the geographic impact of David Radley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Radley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Radley more than expected).

Fields of papers citing papers by David Radley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Radley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Radley. The network helps show where David Radley may publish in the future.

Co-authorship network of co-authors of David Radley

This figure shows the co-authorship network connecting the top 25 collaborators of David Radley. A scholar is included among the top collaborators of David Radley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Radley. David Radley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Madhi, Shabir A., Beate Kampmann, Eric A. F. Simões, et al.. (2025). Preterm Birth Frequency and Associated Outcomes From the MATISSE (Maternal Immunization Study for Safety and Efficacy) Maternal Trial of the Bivalent Respiratory Syncytial Virus Prefusion F Protein Vaccine. Obstetrics and Gynecology. 145(2). 147–156. 10 indexed citations

Saukkoriipi, Annika, Natalie C. Silmon de Monerri, Maija Toropainen, et al.. (2024). Association between anti-capsular IgG levels at birth and risk of invasive group B streptococcus disease in Finnish newborns: a retrospective case–control study. The Lancet Microbe. 5(7). 689–696. 5 indexed citations

Simões, Eric A. F., Shabir A. Madhi, Conrado J. Llapur, et al.. (2022). 91. Establishing Proof of Concept for a Bivalent RSVpreF Subunit Vaccine for Maternal Immunization. Open Forum Infectious Diseases. 9(Supplement_2). 2 indexed citations

Peterson, James T., Agnieszka Zareba, David Fitzpatrick, et al.. (2021). Safety and Immunogenicity of a Respiratory Syncytial Virus Prefusion F Vaccine When Coadministered With a Tetanus, Diphtheria, and Acellular Pertussis Vaccine. The Journal of Infectious Diseases. 225(12). 2077–2086. 31 indexed citations

Beeslaar, Johannes, Judith Absalon, Annaliesa S. Anderson, et al.. (2020). MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infectious Diseases and Therapy. 9(3). 641–656. 4 indexed citations

Kjær, Susanne K., Mari Nygård, Joakim Dillner, et al.. (2017). A 12-Year Follow-up on the Long-Term Effectiveness of the Quadrivalent Human Papillomavirus Vaccine in 4 Nordic Countries. Clinical Infectious Diseases. 66(3). 339–345. 91 indexed citations

Ciprero, Karen L., Rocio D. Marchese, Patrick O. Richard, et al.. (2016). Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes. Human Vaccines & Immunotherapeutics. 12(8). 2135–2141. 3 indexed citations

Radley, David, Alfred J. Saah, & Margaret Stanley. (2015). Persistent infection with human papillomavirus 16 or 18 is strongly linked with high-grade cervical disease. Human Vaccines & Immunotherapeutics. 12(3). 768–772. 46 indexed citations

Luna, Joaquín, et al.. (2013). Long-Term Follow-up Observation of the Safety, Immunogenicity, and Effectiveness of Gardasil™ in Adult Women. PLoS ONE. 8(12). e83431–e83431. 72 indexed citations

10.

Li, Rongcheng, Yanping Li, David Radley, et al.. (2012). Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females. Vaccine. 30(28). 4284–4291. 38 indexed citations

11.

Haupt, Richard M., Cosette M. Wheeler, Darron R. Brown, et al.. (2011). Impact of an HPV6/11/16/18 L1 virus‐like particle vaccine on progression to cervical intraepithelial neoplasia in seropositive women with HPV16/18 infection. International Journal of Cancer. 129(11). 2632–2642. 42 indexed citations

12.

Brown, Darron R., Suzanne M. Garland, Daron G. Ferris, et al.. (2011). The humoral response to Gardasil over four years as defined by Total IgG and competitive Luminex immunoassay. Human Vaccines. 7(2). 230–238. 90 indexed citations

13.

Giuliano, Anna R., Joel M. Palefsky, Stephen E. Goldstone, et al.. (2011). Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males. New England Journal of Medicine. 364(5). 401–411. 821 indexed citations breakdown →

14.

Levin, Myron J., Anna‐Barbara Moscicki, Lin‐Ye Song, et al.. (2010). Safety and Immunogenicity of a Quadrivalent Human Papillomavirus (Types 6, 11, 16, and 18) Vaccine in HIV-Infected Children 7 to 12 Years Old. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(2). 197–204. 133 indexed citations

15.

Díaz‐Mitoma, Francisco, Scott A. Halperin, Bruce Tapiéro, et al.. (2010). Safety and immunogenicity of three different formulations of a liquid hexavalent diphtheria–tetanus–acellular pertussis–inactivated poliovirus–Haemophilus influenzae b conjugate–hepatitis B vaccine at 2, 4, 6 and 12–14 months of age. Vaccine. 29(6). 1324–1331. 8 indexed citations

16.

Vesikari, Timo, Pierre Van Damme, David Radley, et al.. (2010). An Open-Label, Randomized, Multicenter Study of the Safety, Tolerability, and Immunogenicity of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine Given Concomitantly With Diphtheria, Tetanus, Pertussis, and Poliomyelitis Vaccine in Healthy Adolescents 11 to 17 Years of Age. The Pediatric Infectious Disease Journal. 29(4). 314–318. 37 indexed citations

17.

Halperin, Scott A., Joanne M. Langley, Teresa M. Hesley, et al.. (2005). Safety and Immunogenicity of Two Formulations of a Hexavalent Diphtheria-Tetanus-Acellular Pertussis-Inactivated Poliovirus-Haemophilus influenzaeb Conjugate-Hepatitis B Vaccine in 15 to 18 Month-Old Children. Human Vaccines. 1(6). 245–250. 11 indexed citations

18.

Anderson, Edwin L., Sharon E. Frey, David Radley, et al.. (2002). Safety, tolerability and immunogenicity of low dose Haemophilus Influenzae type B conjugated to the outer membrane protein complex of Neisseria Meningitidis group B. The Pediatric Infectious Disease Journal. 21(4). 350–352. 7 indexed citations

19.

Cohen, Marc, Elliott M. Antman, Sabina A. Murphy, & David Radley. (2002). Mode and timing of treatment failure (recurrent ischemic events) after hospital admission for non-ST segment elevation acute coronary syndromes. American Heart Journal. 143(1). 63–69. 19 indexed citations

20.

Goodman, Shaun G., Marc Cohen, Frédérique Bigonzi, et al.. (2000). Randomized trial of low molecular weight heparin (enoxaparin) versus unfractionated heparin for unstable coronary artery disease∗∗∗∗A list of participating ESSENCE Study Group investigators may be found in N Engl J Med 1997;337:447–52.. Journal of the American College of Cardiology. 36(3). 693–698. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact